1558 studies found for:    Farber's Disease
Show Display Options
Rank Status Study
21 Completed
Has Results
Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: bortezomib;   Drug: Prednisone
22 Recruiting Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
Conditions: Multiple Myeloma;   Waldenstrom's Macroglobulinemia;   Smoldering Multiple Myeloma;   Lymphoblastic Lymphoma
Intervention:
23 Completed
Has Results
Adenosine 2A Agonist Lexiscan in Children and Adults With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Lexiscan
24 Completed CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
Conditions: Hematologic Malignancy;   AML;   ALL;   CML;   Multiple Myeloma;   NHL;   Hodgkin's Lymphoma
Intervention: Device: CD+8 T cell depletion
25 Recruiting Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
Condition: Graft Versus Host Disease
Interventions: Drug: Tacrolimus;   Drug: Methotrexate;   Drug: Bortezomib;   Drug: Sirolimus
26 Completed Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy
Condition: Hodgkin's Disease
Interventions: Procedure: Pulmonary Function Tests;   Procedure: CAT Scan
27 Recruiting Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease
Conditions: Sickle Cell Disease;   Sickle Cell Anemia
Intervention: Drug: vorinostat
28 Recruiting Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
Conditions: Non-Hodgkin's Lymphoma;   Hodgkin's Disease;   Leukemia, Lymphocytic, Chronic;   Lymphoproliferative Disorders
Intervention:
29 Terminated Sirolimus and Mycophenolate Mofetil (MMF) as Graft Versus Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Transplantation
Condition: Graft-vs-Host Disease
Intervention: Drug: Sirolimus, MMF
30 Active, not recruiting Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease;   Chronic Graft vs Host Disease;   cGVHD
Intervention:
31 Not yet recruiting LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Prednisone;   Drug: Vinblastine;   Drug: mercaptopurine;   Drug: INDOMETHACIN;   Drug: Methotrexate;   Drug: Cytosine Arabinoside;   Drug: 2-chlorodeoxyadenosine;   Procedure: hematopoietic stem cell transplantation (RIC-HSCT);   Biological: Intravenous immunoglobulin
32 Completed
Has Results
Campath in Chronic GVHD
Condition: Chronic Graft-vs.-Host Disease
Intervention: Drug: Alemtuzumab (Campath)
33 Not yet recruiting An Open Label Phase II Trial of Topical Sirolimus for the Treatment of Refractory Oral Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-Host-Disease;   Oral Mucosal Disease Due to Graft-versus-host Disease
Intervention: Drug: Sirolimus
34 Active, not recruiting Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: GM-K562 vaccine;   Procedure: stem cell transplantation
35 Completed
Has Results
Rituximab for Prevention of Chronic GVHD
Condition: Hematological Malignancies
Interventions: Drug: Rituximab;   Drug: 375 mg/m2 RRituximab
36 Unknown  Socialization of Adult Men With Congenital Hemophilia A or B
Conditions: Hemophilia A;   Hemophilia B
Intervention:
37 Unknown  Laboratory-Treated Peripheral Blood Cell Infusion After Donor Stem Cell Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Biological: anti-thymocyte globulin;   Biological: peripheral blood lymphocyte therapy;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Drug: thiotepa;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: in vitro-treated peripheral blood stem cell transplantation;   Radiation: total-body irradiation
38 Completed
Has Results
RAD001 in Previously Treated Patients With Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Intervention: Drug: RAD001
39 Active, not recruiting Investigation of the Enhancement of the Response to Hepatitis B Vaccine by Lenalidomide (RevlimidTM, CC-5013) in Plasma Cell Dyscrasias
Condition: Plasma Cell Disorder
Interventions: Drug: Lenalidomide;   Drug: Placebo
40 Recruiting A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer
Condition: Prostate Cancer
Interventions: Device: Multiparametric MRI;   Procedure: Prostate biopsy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years